These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31653527)

  • 21. [Prevention of Streptococcus pneumoniae (pneumococcal) infections in adults].
    Ludwig E; Mészner Z;
    Orv Hetil; 2014 Dec; 155(50):1996-2004. PubMed ID: 25481502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of universal pneumococcal vaccination on hospitalizations for pneumonia and meningitis in children in Montevideo, Uruguay.
    Pírez MC; Algorta G; Cedrés A; Sobrero H; Varela A; Giachetto G; Montano A
    Pediatr Infect Dis J; 2011 Aug; 30(8):669-74. PubMed ID: 21407145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence, aetiology and serotype coverage for pneumococcal vaccines of community-acquired pneumonia in adults: a population-based prospective active surveillance study in Brazil.
    Duarte FG; Barberino MG; da Silva Moreira S; Reis JN; Spinardi JR; de Almeida RS; Allen KE; Alexander-Parrish R; Brim R; de Araújo Neto CA; Moreira ED
    BMJ Open; 2022 Apr; 12(4):e059824. PubMed ID: 35428648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the 10-valent pneumococcal conjugate vaccine on hospital admissions in children under three years of age in Iceland.
    Sigurdsson S; Eythorsson E; Erlendsdóttir H; Hrafnkelsson B; Kristinsson KG; Haraldsson Á
    Vaccine; 2020 Mar; 38(12):2707-2714. PubMed ID: 32063434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of administrative records to assess pneumococcal conjugate vaccine impact on pediatric meningitis and pneumonia hospitalizations in Rwanda.
    Gatera M; Uwimana J; Manzi E; Ngabo F; Nwaigwe F; Gessner BD; Moïsi JC
    Vaccine; 2016 Oct; 34(44):5321-5328. PubMed ID: 27639280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States.
    Simonsen L; Taylor RJ; Young-Xu Y; Haber M; May L; Klugman KP
    mBio; 2011 Jan; 2(1):e00309-10. PubMed ID: 21264063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial.
    Huijts SM; Coenjaerts FEJ; Bolkenbaas M; van Werkhoven CH; Grobbee DE; Bonten MJM;
    Clin Microbiol Infect; 2018 Jul; 24(7):764-770. PubMed ID: 29050992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of pneumococcal vaccination on the hospitalization of healthy pediatric patients due to typical Community-Acquired Pneumonia.
    Valdivielso Martínez AI; Ramos Fernández JM; Pérez Frías J; Moreno Pérez D
    Int J Infect Dis; 2020 Sep; 98():194-199. PubMed ID: 32553718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population-level impact of infant 10-valent pneumococcal conjugate vaccination on adult pneumonia hospitalisations in Finland.
    Okasha O; Rinta-Kokko H; Palmu AA; Ruokokoski E; Jokinen J; Nuorti JP
    Thorax; 2018 Mar; 73(3):262-269. PubMed ID: 28988217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses.
    Suarez V; Michel F; Toscano CM; Bierrenbach AL; Gonzales M; Alencar AP; Ruiz Matus C; Andrus JK; de Oliveira LH
    Vaccine; 2016 Sep; 34(39):4738-4743. PubMed ID: 27521230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study.
    Fathima P; Gidding HF; McIntyre PB; Snelling TL; McCallum L; de Klerk N; Blyth CC; Liu B; Moore HC
    Lancet Child Adolesc Health; 2019 Oct; 3(10):713-724. PubMed ID: 31439496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognising pneumonia burden through prevention.
    Grijalva CG
    Vaccine; 2009 Aug; 27 Suppl 3():C6-8. PubMed ID: 19540635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18.
    Pick H; Daniel P; Rodrigo C; Bewick T; Ashton D; Lawrence H; Baskaran V; Edwards-Pritchard RC; Sheppard C; Eletu SD; Rose S; Litt D; Fry NK; Ladhani S; Chand M; Trotter C; McKeever TM; Lim WS
    Thorax; 2020 Jan; 75(1):38-49. PubMed ID: 31594801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of pneumococcal conjugate vaccine on pneumonia hospitalization and mortality in children and elderly in Ecuador: Time series analyses.
    Jimbo Sotomayor R; Toscano CM; Sánchez Choez X; Vilema Ortíz M; Rivas Condo J; Ghisays G; Haneuse S; Weinberger DM; McGee G; de Oliveira LH
    Vaccine; 2020 Oct; 38(45):7033-7039. PubMed ID: 32981782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction.
    Scotta MC; Veras TN; Klein PC; Tronco V; Polack FP; Mattiello R; Pitrez PMC; Jones MH; Stein RT; Pinto LA
    Vaccine; 2014 Jul; 32(35):4495-4499. PubMed ID: 24958703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a phased pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a study protocol for a prospective observational study and lessons learned.
    La Vincente SF; von Mollendorf C; Ulziibayar M; Satzke C; Dashtseren L; Fox KK; Dunne EM; Nguyen CD; de Campo J; de Campo M; Thomson H; Surenkhand G; Demberelsuren S; Bujinlkham S; Do LAH; Narangerel D; Cherian T; Mungun T; Mulholland EK
    BMC Public Health; 2019 Mar; 19(1):333. PubMed ID: 30898094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.
    Li ST; Tancredi DJ
    Pediatrics; 2010 Jan; 125(1):26-33. PubMed ID: 19948570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua.
    Becker-Dreps S; Amaya E; Liu L; Moreno G; Rocha J; Briceño R; Alemán J; Hudgens MG; Woods CW; Weber DJ
    Pediatr Infect Dis J; 2014 Jun; 33(6):637-42. PubMed ID: 24445827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determining the contribution of Streptococcus pneumoniae to community-acquired pneumonia in Australia.
    Yin JK; Jayasinghe SH; Charles PG; King C; Chiu CK; Menzies RI; McIntyre PB
    Med J Aust; 2017 Nov; 207(9):396-400. PubMed ID: 29092707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997-2008.
    Koshy E; Murray J; Bottle A; Sharland M; Saxena S
    Thorax; 2010 Sep; 65(9):770-4. PubMed ID: 20805169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.